Ignite Creation Date:
2025-12-24 @ 2:56 PM
Ignite Modification Date:
2026-03-01 @ 11:52 AM
Study NCT ID:
NCT03311659
Status:
COMPLETED
Last Update Posted:
2020-10-27
First Post:
2017-10-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluation of Immunogenicity, Safety and Reactogenicity of GSK Biologicals' Boostrix Vaccine Administered as a Booster Dose in Healthy Russian Subjects
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-01-26
Start Date Type:
ACTUAL
Primary Completion Date:
2018-08-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-08-31
Completion Date Type:
ACTUAL
First Submit Date:
2017-10-06
First Submit QC Date:
None
Study First Post Date:
2017-10-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2019-08-29
Results First Submit QC Date:
None
Results First Post Date:
2019-10-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-10-05
Last Update Post Date:
2020-10-27
Last Update Post Date Type:
ACTUAL